Zymeworks (ZYME)
29.19
-0.71 (2.37%)
Upcoming Events
Latest Headlines
Zymeworks (ZYME) PT Raised to $33 at JPMorgan
September 3, 2026 8:32 AM - StreetInsider
Zymeworks (ZYME) PT Raised to $55 at H.C. Wainwright
August 26, 2026 6:41 AM - StreetInsider
Zymeworks (ZYME) Reiterated at Market Outperform by Citizens on FDA Approval for Zani
August 26, 2026 4:21 AM - StreetInsider
Zymeworks (ZYME) PT Raised to $38 at Citi
August 25, 2026 4:02 PM - StreetInsider
Form 8-K Zymeworks Inc. For: Aug 25
August 25, 2026 10:54 AM - SEC Filing
Zymeworks Announces Participation in Upcoming Investor Conferences
August 11, 2026 6:00 AM - StreetInsider
Zymeworks (ZYME) PT Raised to $44 at B.Riley
August 10, 2026 8:18 AM - StreetInsider
Zymeworks (ZYME) PT Lowered to $46 at Stifel
August 7, 2026 10:29 AM - StreetInsider
Zymeworks (ZYME) PT Raised to $40 at Wells Fargo
August 7, 2026 8:23 AM - StreetInsider
Zymeworks (ZYME) Misses Q2 EPS by 25c
August 6, 2026 5:35 PM - StreetInsider
Form 10-Q Zymeworks Inc. For: Jun 30
August 6, 2026 4:16 PM - SEC Filing
Form 8-K Zymeworks Inc. For: Aug 06
August 6, 2026 4:13 PM - SEC Filing
Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results
August 6, 2026 4:06 PM - Globe NewsWire
Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results
August 6, 2026 4:05 PM - StreetInsider
Zymeworks (ZYME) PT Raised to $51 at H.C. Wainwright
August 6, 2026 6:55 AM - StreetInsider
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
July 16, 2026 6:00 AM - StreetInsider
H.C. Wainwright Downgrades Theravance Biopharma (TBPH) to Neutral
July 7, 2026 7:37 AM - StreetInsider
Zymeworks (ZYME) PT Raised to $31 at Truist Securities
July 7, 2026 7:09 AM - StreetInsider
Form 4 Zymeworks Inc. For: Jul 06 Filed by: Hollywood Mark
July 6, 2026 5:29 PM - SEC Filing
B. Riley: 'Aggressively Buying the ZYME Dip'
June 29, 2026 10:27 AM - StreetInsider
BTIG Downgrades Theravance Biopharma (TBPH) to Neutral
June 29, 2026 9:20 AM - StreetInsider
Jones Trading Downgrades Theravance Biopharma (TBPH) to Hold
June 29, 2026 8:34 AM - StreetInsider
Form 8-K Zymeworks Inc. For: Jun 28
June 29, 2026 7:20 AM - SEC Filing
Zymeworks (ZYME) Reiterated at Buy by Stifel: 'Significantly Undervalued'
June 29, 2026 7:19 AM - StreetInsider
Zymeworks to buy Theravance Biopharma for $17 per share
June 29, 2026 6:00 AM - StreetInsider
Zymeworks to Acquire Theravance Biopharma, Inc.
June 29, 2026 6:00 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Zymeworks (ZYME)
June 22, 2026 6:59 AM - StreetInsider
Gandeeva and Zymeworks partner on cryo-EM antibody structure work
June 18, 2026 8:05 AM - StreetInsider
Gandeeva and Zymeworks Use Cryo-EM to Accelerate Antibody Drug Discovery
June 18, 2026 8:00 AM - PR NewsWire
Zymeworks (ZYME) Reiterated at Market Outperform by Citizens on ZW191 Efficacy Data
June 16, 2026 5:25 AM - StreetInsider
Zymeworks reports phase 1 data for cancer drug ZW191
June 14, 2026 6:05 PM - StreetInsider
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026
June 14, 2026 6:05 PM - StreetInsider
Truist Securities Assumes Zymeworks (ZYME) at Buy
June 9, 2026 6:08 AM - StreetInsider
Full Article List
